Amesite
AMST
8 hedge funds and large institutions have $248K invested in Amesite in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
33% more funds holding
Funds holding: 6 → 8 (+2)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
0.07% less ownership
Funds ownership: 0.36% → 0.29% (-0.07%)
31% less capital invested
Capital invested by funds: $358K → $248K (-$110K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$170K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$73.6K |
| 3 |
BlackRock
New York
|
+$42.5K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.36K |
| 5 |
Morgan Stanley
New York
|
+$974 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LWM
Laidlaw Wealth Management
New York City,
New York
|
-$243K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$260 |
AMST Hedge Fund Activity: Q1 2021 in Review
8 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Amesite (AMST) for Q1 2021, worth a combined $248K — down 31% from $358K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new AMST positions and 1 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, opening a new position worth an estimated $170K. The largest seller was Laidlaw Wealth Management, exiting entirely with an estimated $243K sold.
- 8 institutional investors held Amesite (AMST) as of Q1 2021, up from 6 in Q4 2020.
- Funds reported $248K of Amesite stock for Q1 2021, down 31% quarter-over-quarter.
- 4 funds opened new Amesite positions in Q1 2021 and 1 closed out, a net change of +3 holders.
- The largest Amesite buyer in Q1 2021 was Vanguard Group, an estimated $170K added.
- The largest Amesite seller in Q1 2021 was Laidlaw Wealth Management, an estimated $243K sold.
Based on aggregated 13F filings for Q1 2021.